NCT01445873View on ClinicalTrials.gov

Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

December 1, 2009

Primary Completion Date

March 28, 2011

Study Completion Date

March 28, 2011

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Sitaxentan sodium

Sitaxentan sodium 100 mg / day

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY